Juàn Fueyo
机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0001-6941-2335
发表论文 573 篇 · 总被引 23089 次 · h-index 55
代表论文
- PACM-04 ONCOLYTIC ADENOVIRUS RGDOX INDUCES SYSTEMIC CD8+ T CELL–MEDIATED IMMUNITY ACROSS INTRACRANIAL MELANOMA METASTASES: RATIONALE FOR A PHASE I TRIAL (2026 · Neuro-Oncology Advances)
- Diverse origin and nature of tumor-infiltrating lymphocytes: the infection hypothesis (2026 · Journal for ImmunoTherapy of Cancer)
- Supplementary Table S15 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET) (2026)
- Supplementary Table S12 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET) (2026)
- Supplementary Table S8 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET) (2026)
- Supplementary Table S33 from Systemic Immune Correlates of Long-term Survival after Delta-24-RGD Based on the Therapeutic Adenovirus for Recurrent Glioblastoma Effect Trial (TARGET) (2026)